Raleigh, NC, United States of America

Michael David Tomalski


Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michael David Tomalski: Innovator in Insecticide Development

Introduction

Michael David Tomalski is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of insecticides. With a total of 4 patents to his name, Tomalski's work focuses on the modulation of lepidopteran glutamate-gated chloride channels.

Latest Patents

Tomalski's latest patents include innovations related to the Heliothis glutamate receptor. The first patent is directed to a nucleic acid encoding a lepidopteran glutamate-gated chloride channel. This invention also provides vectors and host cells comprising the nucleic acid. Additionally, it outlines a method for identifying agents that modulate the activity of this channel, which can be useful as insecticides. The second patent reiterates similar concepts, emphasizing the importance of these agents in pest control.

Career Highlights

Throughout his career, Tomalski has worked with prominent companies in the agricultural biotechnology sector. Notable employers include Aventis Cropscience S.A. and Rhone-Poulenc, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for pest management.

Collaborations

Tomalski has collaborated with several professionals in his field, including Xiao-Zhuo Michelle Wang and Xavier Georges Sarda. These collaborations have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Michael David Tomalski is a distinguished inventor whose work in biotechnology has paved the way for advancements in insecticide development. His patents reflect a commitment to innovation and a deep understanding of pest control mechanisms.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…